BOJHT
ITCI

Bank of Jackson Hole Trust’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bank of Jackson Hole Trust’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-22
Closed -$2.82K – 481
2025
Q1 		$2.82K Buy
+22
New +$2.74K ﹤0.01% 426

Other funds holding ITCI

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
KIM
Kestra Investment Management Austin, Texas $5.16B AUM 18.64% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Bank of Jackson Hole Trust's ITCI Position: Q2 2025 in Review

Bank of Jackson Hole Trust sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 22 shares — an estimated $2.82K sold.

Bank of Jackson Hole Trust first reported a position in ITCI in Q1 2025 and held it in 1 quarter. The position peaked at $2.82K in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

  • Bank of Jackson Hole Trust reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
  • Bank of Jackson Hole Trust sold 22 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $2.82K.
  • Bank of Jackson Hole Trust first reported a position in Intra-Cellular Therapies Inc. in Q1 2025 and held it in 1 quarter.
  • Bank of Jackson Hole Trust's Intra-Cellular Therapies Inc. position peaked at $2.82K in Q1 2025.
  • 4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Bank of Jackson Hole Trust's 13F filing for Q2 2025, filed 1 Aug 2025.